Forensic scientist Mark Ruefenacht, who has type 1 diabetes, tells Diabetes Health publisher Nadia Al-Samarrie how he realized that dogs can be a major defense against life-threatening episodes of hypoglycemia. That insight led him to found Dogs for Diabetics ("D4D"), a Concord, California-based organization that trains dogs to alert their masters when they sense low blood sugar. D4D's website is located at www.dogs4diabetics.com/
Mike Golic is the co-host of ESPN's wildly popular radio show, "Mike and Mike in the Morning." Before beginning work as a broadcaster in 1995, he played for nine years as a defensive tackle in the National Football League, including stints with the Houston Oilers, Philadelphia Eagles, and Miami Dolphins. About five years ago, he was diagnosed with type 2 diabetes. Since then, he has become involved in getting the word out about type 2, including the potential danger of hypoglycemia. He is a spokesman for "Blood Sugar Basics," a website and outreach program co-sponsored by Merck and the American College of Endocrinology.
It is raining today. Kolumbo, my hypoglycemia alert dog, hates the rain. I think I have the only Labrador in the world that hates getting wet.
I opened the screen door this morning to feel the breeze and hear the rain. Unfortunately, while the door was open, a fly decided to come inside. When I say that Kolumbo is a lazy dog, I really mean it. He lay on his bed and watched the fly go around and around. then opened his mouth, thinking that the fly might just go in. I heard the snap of his teeth as he tried to get the fly.
A brand new insulin will soon be on pharmacy shelves in the United States if Danish pharmaceutical company Novo Nordisk has its way. The company has filed for approval from the Food and Drug Administration to sell insulin degludec, an original formulation that lasts an extra-long time.
Insulin degludec is injected only once a day. Once under the skin, the dose of insulin is absorbed slowly and consistently, allowing for better nighttime control, according to Novo. Most importantly, test subjects had a low rate of hypoglycemia on the drug.
When people are diagnosed with diabetes, things can seem pretty overwhelming. In a short time, they have to absorb a daunting amount of information and start making significant decisions about the way they live their lives.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.